Abo, Finland

Preethy Paul

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Abo Akademi. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Preethy Paul. Retrieved from https://idiyas.com/inventor/preethy-paul-3kz4ch4t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Preethy Paul: Innovator in HPV-Induced Carcinoma Treatment

Introduction

Preethy Paul is a notable inventor based in Åbo, Finland. She has made significant contributions to the field of medical research, particularly in the treatment of HPV-induced carcinoma. Her innovative work has led to the development of a unique compound that holds promise for cancer treatment.

Latest Patents

Preethy Paul holds 1 patent for her invention titled "Compounds for the treatment of HPV-induced carcinoma - A compound of Formula 1." This patent represents a crucial step forward in addressing a significant health issue affecting many individuals worldwide.

Career Highlights

Preethy is currently affiliated with Abo Akademi, where she continues her research and development efforts. Her work at the university has allowed her to explore new avenues in cancer treatment and contribute to the academic community.

Collaborations

Throughout her career, Preethy has collaborated with esteemed colleagues, including Senthil Kumar Rajendran and Yury Brusentsev. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Preethy Paul's contributions to the field of cancer treatment exemplify the importance of innovation in medicine. Her work not only advances scientific knowledge but also offers hope for improved therapies for HPV-induced carcinoma.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…